Sinovac's unit files application for public use of its COVID-19 vaccine to Chinese regulator
- Country:
- China
Sinovac Biotech said on Wednesday its unit Sinovac Life Science has filed application for the public use of its COVID-19 vaccine to Chinese medical product regulator.
The application has been accepted by National Medical Products Administration for processing, Sinovac Biotech said in a statement.
Google News